SCHOTT Pharma AG & Co. KGaA (1SXP.F)

EUR 23.72

(0.08%)

Operating Expenses Summary of SCHOTT Pharma AG & Co. KGaA

  • SCHOTT Pharma AG & Co. KGaA's latest annual operating expenses in 2023 was 124.1 Million EUR , up 13.95% from previous year.
  • SCHOTT Pharma AG & Co. KGaA's latest quarterly operating expenses in 2024 Q2 was 38.3 Million EUR , down -77.98% from previous quarter.
  • SCHOTT Pharma AG & Co. KGaA reported a annual operating expenses of 127.74 Million EUR in annual operating expenses 2022, up 15.17% from previous year.
  • SCHOTT Pharma AG & Co. KGaA reported a annual operating expenses of 110.92 Million EUR in annual operating expenses 2021, up 6.25% from previous year.
  • SCHOTT Pharma AG & Co. KGaA reported a quarterly operating expenses of 38.3 Million EUR for 2024 Q2, down -77.98% from previous quarter.
  • SCHOTT Pharma AG & Co. KGaA reported a quarterly operating expenses of 196 Million EUR for 2024 Q3, down -23.94% from previous quarter.

Annual Operating Expenses Chart of SCHOTT Pharma AG & Co. KGaA (2023 - 2020)

Historical Annual Operating Expenses of SCHOTT Pharma AG & Co. KGaA (2023 - 2020)

Year Operating Expenses Operating Expenses Growth
2023 124.1 Million EUR 13.95%
2022 127.74 Million EUR 15.17%
2021 110.92 Million EUR 6.25%
2020 104.39 Million EUR 0.0%

Peer Operating Expenses Comparison of SCHOTT Pharma AG & Co. KGaA

Name Operating Expenses Operating Expenses Difference
Carl Zeiss Meditec AG 878.62 Million EUR 85.875%
Fielmann Aktiengesellschaft 289.86 Million EUR 57.185%
Gerresheimer AG 383.92 Million EUR 67.674%
Sartorius Aktiengesellschaft 1.02 Billion EUR 87.879%
Sartorius Aktiengesellschaft 1.02 Billion EUR 87.862%